Allergy Therapeutics Plc
(LSE) AGY
Allergy Therapeutics Plc Financials at a Glance
Market Cap
$68.39B
Revenue (TTM)
$112.95M
Net Income (TTM)
$84.61M
EPS (TTM)
$-0.99
P/E Ratio
-10.91
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Price
$10.80
Volume
55,736
Open
$10.70
Price
$10.80
Volume
55,736
Open
$10.70
Previous Close
$10.80
Daily Range
$10.00 - $11.00
52-Week Range
$5.60 - $12.10
Dividend
$0.00
Beta (Volatility)
0.13 (Low)
Price
$10.80
Volume
55,736
Open
$10.70
Previous Close
$10.80
Daily Range
$10.00 - $11.00
52-Week Range
$5.60 - $12.10
AGY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Allergy Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
612
CEO
Manuel Llobet, MBA
Website
www.allergytherapeutics.comHeadquarters
Worthing, BN14 8SA, GB
AGY Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
-60%
Net Income Margin
-85%
Return on Equity
0%
Return on Capital
-89%
Return on Assets
-69%
Earnings Yield
-9.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$68.39B
Shares Outstanding
6.33B
Volume
55.74K
Short Interest
0.00%
Avg. Volume
293.19K
Financials (TTM)
Gross Profit
$25.13M
Operating Income
$29.50M
EBITDA
$29.43M
Operating Cash Flow
$28.72M
Capital Expenditure
$3.26M
Free Cash Flow
$31.98M
Cash & ST Invst.
$12.79M
Total Debt
$60.09M
Allergy Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$36.28M
+8.1%
Gross Profit
$19.32M
-5.8%
Gross Margin
53.26%
N/A
Market Cap
$68.39B
N/A
Market Cap/Employee
$111.75M
N/A
Employees
612
N/A
Net Income
$19.92M
-27.3%
EBITDA
$9.76M
-0.6%
Quarterly Fundamentals
Net Cash
$16.67M
-553.9%
Accounts Receivable
$10.98M
+10.5%
Inventory
$13.79M
+15.9%
Long Term Debt
$24.79M
+206.0%
Short Term Debt
$1.96M
+12.2%
Return on Assets
-68.96%
N/A
Return on Invested Capital
-88.54%
N/A
Free Cash Flow
$14.52M
-14.9%
Operating Cash Flow
$11.71M
-8.7%